endometrial cancer
Foundation Medicine, Karyopharm Therapeutics Partnering on Endometrial Cancer CDx
The test would help identify patients who have advanced or recurrent TP53 wild-type endometrial cancer and could benefit from the experimental drug Xpovio.
European Team Publishes Molecular Endometrial Cancer Test; Startup Sola Dx Plans Fall Launch
Premium
Called WID-qEC, the test uses quantitative PCR methylation profiling to diagnose endometrial cancer in women presenting with symptoms.
Roche Nabs FDA Label Expansion for Ventana CDx Panel
The immunohistochemistry companion diagnostic helps identify patients with solid tumors that are deficient in DNA mismatch repair.
Akoya Biosciences, Acrivon Therapeutics Partner to Develop CDx
The companies will codevelop, validate, and commercialize a companion diagnostic for Acrivon's targeted DNA damage response inhibitor therapy, ACR-368.
Arquer Dx Developing Urine-Based Protein Biomarker Tests to Detect Bladder, Endometrial Cancers
Premium
Arquer's assays use mouse monoclonal antibodies to detect levels of MCM5 proteins in cells exfoliated into urine to detect either bladder or endometrial cancers.
Nov 25, 2019
A*STAR Spinoff, IMCB Establish Immuno-Oncology Lab
Jul 11, 2019